Kane Biotech Inc. (CVE:KNE – Get Free Report) was down 4.5% during mid-day trading on Monday . The stock traded as low as C$0.11 and last traded at C$0.11. 26,500 shares changed hands during mid-day trading, a decline of 22% from the average daily volume of 34,000 shares. The stock had previously closed at C$0.11.
Kane Biotech Price Performance
The stock has a market cap of C$13.91 million, a price-to-earnings ratio of -3.50 and a beta of 0.52. The company has a current ratio of 0.82, a quick ratio of 0.39 and a debt-to-equity ratio of 1,164.24. The stock has a 50-day moving average price of C$0.11 and a two-hundred day moving average price of C$0.13.
Kane Biotech Company Profile
Kane Biotech Inc, a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine for treating wounds and otic infections.
Featured Stories
- Five stocks we like better than Kane Biotech
- How to Invest in Biotech Stocks
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- Compound Interest and Why It Matters When Investing
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- How Cigna Remains at the Top of the Health Insurance Food Chain
Receive News & Ratings for Kane Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kane Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
